Therapy of Coagulation Factor VIII Autoantibodies with Long-term Extracorporeal Protein A Adsorption and Immunosuppression

Lusher, 1995, Considerations for current and future management of haemophilia and its complications, Haemophilia, 1, 2, 10.1111/j.1365-2516.1995.tb00032.x Green, 1981, A survey of 215 non-hemophilic patients with inhibitors to factor VIII, Thromb and Haemost, 45, 200, 10.1055/s-0038-1650169 Nilsson, 1981, A procedure for removing high titer antibodies by extracorporeal protein A-sepharose adsorption in hemophilia: substitution therapy and surgery in a patient with hemophilia B and antibodies, Blood, 58, 38, 10.1182/blood.V58.1.38.38 Brackmann, 1996, Immune tolerance for the treatment of factor VIII inhibitors—twenty years ‘Bonn Protocol’, Vox Sang, 70, 30, 10.1111/j.1423-0410.1996.tb01346.x Nilsson, 1993, Treatment of patients with factor VIII and IX inhibitors, Thromb and Haemost, 70, 56, 10.1055/s-0038-1646159 Fulcher, 1987, FVIII inhibitor IgG subclass and FVIII polypeptide specifity determined by immunoblotting, Blood, 69, 1475, 10.1182/blood.V69.5.1475.1475 Grossmann, 1996, Diagnose und Therapie eines erworbenen Faktor-VIII-Inhibitors in Kombination mit Lupus-Antikoagulanzien, Dtsch med Wschr, 121, 906, 10.1055/s-2008-1043086 Gjoerstrup, 1991, Kinetic aspects of the removal of IgG and inhibitors in haemophiliacs using protein A immunoadsorption, Vox Sanguinis, 61, 244, 10.1111/j.1423-0410.1991.tb00954.x Gunzer U, Kirch T, Klink M et al.: Cytaphereses (CA) and plasmadepletion (PD), a method to activate autoaggression (AAG) or myeloproliferation (MPS): Some observations to clinical use. Blut 1987; 55:389. Mansouri-Taleghani, 1987, Plasmapheresis and immunosuppression in idiopathic thrombocytopenic purpura, Blut, 55, 396 Schroeder, 1987, Synchronization of plasmapheresis and pulse cyclophosphamide in severe systemic lupus erythematosus, Ann Int Med, 107, 344, 10.7326/0003-4819-107-2-344